Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aung Ko Win

Showing results (91-100 of 135) with videos related to

Pageof 14
Sort By:
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 11, 2012
Immunohistochemical testing of conventional adenomas for loss of expression of mismatch repair proteins in Lynch syndrome mutation carriers: a case series from the Australasian site of the colon cancer family registryMichael D Walsh, Daniel D Buchanan, Sally-Ann Pearson, et al.
Journal of the National Cancer Institute|June 26, 2015
Aspirin, Ibuprofen, and the Risk of Colorectal Cancer in Lynch SyndromeDriss Ait Ouakrim, Seyedeh Ghazaleh Dashti, Rowena Chau, et al.
British Journal of Cancer|January 10, 2024
Intratumoral presence of the genotoxic gut bacteria pks<sup>+</sup> E. coli, Enterotoxigenic Bacteroides fragilis, and Fusobacterium nucleatum and their association with clinicopathological and molecular features of colorectal cancerJihoon E Joo, Yen Lin Chu, Peter Georgeson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 15, 2012
Colorectal and other cancer risks for carriers and noncarriers from families with a DNA mismatch repair gene mutation: a prospective cohort studyAung Ko Win, Joanne P Young, Noralane M Lindor, et al.
Gastroenterology|January 22, 2014
Risk of colorectal cancer for carriers of mutations in MUTYH, with and without a family history of cancerAung Ko Win, James G Dowty, Sean P Cleary, et al.
BMJ Open|February 21, 2016
Germline mutations in PMS2 and MLH1 in individuals with solitary loss of PMS2 expression in colorectal carcinomas from the Colon Cancer Family Registry CohortChristophe Rosty, Mark Clendenning, Michael D Walsh, et al.
Gut|March 12, 2014
Role of tumour molecular and pathology features to estimate colorectal cancer risk for first-degree relativesAung Ko Win, Daniel D Buchanan, Christophe Rosty, et al.
International Journal of Cancer|May 20, 2016
Risk of extracolonic cancers for people with biallelic and monoallelic mutations in MUTYHAung Ko Win, Jeanette C Reece, James G Dowty, et al.
International Journal of Epidemiology|April 12, 2016
Multivitamin, calcium and folic acid supplements and the risk of colorectal cancer in Lynch syndromeRowena Chau, Seyedeh Ghazaleh Dashti, Driss Ait Ouakrim, et al.
Plos One|April 27, 2018
Genetic susceptibility markers for a breast-colorectal cancer phenotype: Exploratory results from genome-wide association studiesMala Pande, Aron Joon, Abenaa M Brewster, et al.
Pageof 14

Showing results (91-100 of 135) with videos related to

Sort By:
Pageof 14
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 11, 2012
Immunohistochemical testing of conventional adenomas for loss of expression of mismatch repair proteins in Lynch syndrome mutation carriers: a case series from the Australasian site of the colon cancer family registryMichael D Walsh, Daniel D Buchanan, Sally-Ann Pearson, et al.
Journal of the National Cancer Institute|June 26, 2015
Aspirin, Ibuprofen, and the Risk of Colorectal Cancer in Lynch SyndromeDriss Ait Ouakrim, Seyedeh Ghazaleh Dashti, Rowena Chau, et al.
British Journal of Cancer|January 10, 2024
Intratumoral presence of the genotoxic gut bacteria pks<sup>+</sup> E. coli, Enterotoxigenic Bacteroides fragilis, and Fusobacterium nucleatum and their association with clinicopathological and molecular features of colorectal cancerJihoon E Joo, Yen Lin Chu, Peter Georgeson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 15, 2012
Colorectal and other cancer risks for carriers and noncarriers from families with a DNA mismatch repair gene mutation: a prospective cohort studyAung Ko Win, Joanne P Young, Noralane M Lindor, et al.
Gastroenterology|January 22, 2014
Risk of colorectal cancer for carriers of mutations in MUTYH, with and without a family history of cancerAung Ko Win, James G Dowty, Sean P Cleary, et al.
BMJ Open|February 21, 2016
Germline mutations in PMS2 and MLH1 in individuals with solitary loss of PMS2 expression in colorectal carcinomas from the Colon Cancer Family Registry CohortChristophe Rosty, Mark Clendenning, Michael D Walsh, et al.
Gut|March 12, 2014
Role of tumour molecular and pathology features to estimate colorectal cancer risk for first-degree relativesAung Ko Win, Daniel D Buchanan, Christophe Rosty, et al.
International Journal of Cancer|May 20, 2016
Risk of extracolonic cancers for people with biallelic and monoallelic mutations in MUTYHAung Ko Win, Jeanette C Reece, James G Dowty, et al.
International Journal of Epidemiology|April 12, 2016
Multivitamin, calcium and folic acid supplements and the risk of colorectal cancer in Lynch syndromeRowena Chau, Seyedeh Ghazaleh Dashti, Driss Ait Ouakrim, et al.
Plos One|April 27, 2018
Genetic susceptibility markers for a breast-colorectal cancer phenotype: Exploratory results from genome-wide association studiesMala Pande, Aron Joon, Abenaa M Brewster, et al.
Pageof 14